Monoclonal antibody | |
---|---|
Type | ? |
Clinical data | |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
UNII | |
KEGG |
Levilimab is an anti-IL-6 monoclonal antibody initially developed to treat rheumatoid arthritis. In 2020, it was approved as a treatment for COVID-19 in Russia. [1] [2] [3]